Literature DB >> 1740114

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.

W P Burmeister1, R W Ruigrok, S Cusack.   

Abstract

Influenza virus neuraminidase catalyses the cleavage of terminal sialic acid, the viral receptor, from carbohydrate chains on glycoproteins and glycolipids. We present the crystal structure of the enzymatically active head of influenza B virus neuraminidase from the strain B/Beijing/1/87. The native structure has been refined to a crystallographic R-factor of 14.8% at 2.2 A resolution and its complex with sialic acid refined at 2.8 A resolution. The overall fold of the molecule is very similar to the already known structure of neuraminidase from influenza A virus, with which there is amino acid sequence homology of approximately 30%. Two calcium binding sites have been identified. One of them, previously undescribed, is located between the active site and a large surface antigenic loop. The calcium ion is octahedrally co-ordinated by five oxygen atoms from the protein and one water molecule. Sequence comparisons suggest that this calcium site should occur in all influenza A and B virus neuraminidases. Soaking of sialic acid into the crystals has enabled the mode of binding of the reaction product in the putative active site pocket to be revealed. All the large side groups of the sialic acid are equatorial and are specifically recognized by nine fully conserved active site residues. These in turn are stabilized by a second shell of 10 highly conserved residues principally by an extensive network of hydrogen bonds.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740114      PMCID: PMC556424          DOI: 10.1002/j.1460-2075.1992.tb05026.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  27 in total

1.  Crystallization and preliminary X-ray analyses of two neuraminidases from influenza B virus strains B/Hong Kong/8/73 and B/Lee/40.

Authors:  P J Bossart; Y S Babu; W J Cook; G M Air; W G Laver
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

2.  Three-dimensional structure of a complex of antibody with influenza virus neuraminidase.

Authors:  P M Colman; W G Laver; J N Varghese; A T Baker; P A Tulloch; G M Air; R G Webster
Journal:  Nature       Date:  1987 Mar 26-Apr 1       Impact factor: 49.962

3.  New crystalline forms of neuraminidase of type B human influenza virus.

Authors:  Y J Lin; M Luo; W G Laver; G M Air; C D Smith; R G Webster
Journal:  J Mol Biol       Date:  1990-08-05       Impact factor: 5.469

4.  Cloning and sequencing of a Clostridium perfringens sialidase gene.

Authors:  P Roggentin; B Rothe; F Lottspeich; R Schauer
Journal:  FEBS Lett       Date:  1988-09-26       Impact factor: 4.124

Review 5.  Antibody recognition of the influenza virus neuraminidase.

Authors:  G M Air; W G Laver; R G Webster; M C Els; M Luo
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

6.  Crystal structures of neuraminidase-antibody complexes.

Authors:  W R Tulip; J N Varghese; R G Webster; G M Air; W G Laver; P M Colman
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

7.  Catalytic properties of the A/H3N2 influenza neuraminidases: influence of antigenic variations.

Authors:  C Deshairs; N Kessler; M Aymard; G A Quash
Journal:  J Gen Virol       Date:  1986-03       Impact factor: 3.891

8.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.

Authors:  W Weis; J H Brown; S Cusack; J C Paulson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

9.  Cloning, sequencing and expression of a sialidase gene from Clostridium sordellii G12.

Authors:  B Rothe; P Roggentin; R Frank; H Blöcker; R Schauer
Journal:  J Gen Microbiol       Date:  1989-11

10.  Using known substructures in protein model building and crystallography.

Authors:  T A Jones; S Thirup
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

View more
  94 in total

1.  The influenza hemagglutinin fusion domain is an amphipathic helical hairpin that functions by inducing membrane curvature.

Authors:  Sean T Smrt; Adrian W Draney; Justin L Lorieau
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

2.  Effects of site-specific mutations on the enzymatic properties of a sialidase from Clostridium perfringens.

Authors:  T Roggentin; R G Kleineidam; R Schauer; P Roggentin
Journal:  Glycoconj J       Date:  1992-10       Impact factor: 2.916

3.  Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases.

Authors:  J N Varghese; P M Colman; A van Donkelaar; T J Blick; A Sahasrabudhe; J L McKimm-Breschkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.

Authors:  Hui-Ling Yen; Erich Hoffmann; Garry Taylor; Christoph Scholtissek; Arnold S Monto; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.

Authors:  Jennifer L McKimm-Breschkin; Janelle Williams; Susan Barrett; Kim Jachno; Mandy McDonald; Peter G Mohr; Takehiko Saito; Masato Tashiro
Journal:  J Antimicrob Chemother       Date:  2013-06-11       Impact factor: 5.790

Review 6.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

7.  Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.

Authors:  J N Varghese; V C Epa; P M Colman
Journal:  Protein Sci       Date:  1995-06       Impact factor: 6.725

8.  Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase.

Authors:  S Shibata; F Yamamoto-Goshima; K Maeno; T Hanaichi; Y Fujita; K Nakajima; M Imai; T Komatsu; S Sugiura
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.

Authors:  N T Wetherall; T Trivedi; J Zeller; C Hodges-Savola; J L McKimm-Breschkin; M Zambon; F G Hayden
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  A novel mechanism for the acquisition of virulence by a human influenza A virus.

Authors:  H Goto; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.